LianBio (LIAN) Competitors $0.26 +0.01 (+4.87%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends LIAN vs. LPTX, TARA, MGX, JMAC, INMB, XFOR, ADVM, CRDL, DERM, and ANROShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include Leap Therapeutics (LPTX), Protara Therapeutics (TARA), Metagenomi (MGX), Maxpro Capital Acquisition (JMAC), INmune Bio (INMB), X4 Pharmaceuticals (XFOR), Adverum Biotechnologies (ADVM), Cardiol Therapeutics (CRDL), Journey Medical (DERM), and Alto Neuroscience (ANRO). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Leap Therapeutics Protara Therapeutics Metagenomi Maxpro Capital Acquisition INmune Bio X4 Pharmaceuticals Adverum Biotechnologies Cardiol Therapeutics Journey Medical Alto Neuroscience LianBio (NASDAQ:LIAN) and Leap Therapeutics (NASDAQ:LPTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings. Is LIAN or LPTX more profitable? LianBio's return on equity of -33.17% beat Leap Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets LianBioN/A -33.17% -30.19% Leap Therapeutics N/A -116.24%-93.18% Do analysts prefer LIAN or LPTX? LianBio currently has a consensus price target of $3.50, suggesting a potential upside of 1,220.75%. Leap Therapeutics has a consensus price target of $7.50, suggesting a potential upside of 157.73%. Given LianBio's higher possible upside, analysts clearly believe LianBio is more favorable than Leap Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Leap Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer LIAN or LPTX? In the previous week, LianBio's average media sentiment score of 0.00 equaled Leap Therapeutics'average media sentiment score. Company Overall Sentiment LianBio Neutral Leap Therapeutics Neutral Do institutionals & insiders believe in LIAN or LPTX? 74.8% of LianBio shares are owned by institutional investors. Comparatively, 30.5% of Leap Therapeutics shares are owned by institutional investors. 7.6% of LianBio shares are owned by insiders. Comparatively, 5.4% of Leap Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, LIAN or LPTX? LianBio has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Leap Therapeutics has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500. Which has higher valuation and earnings, LIAN or LPTX? Leap Therapeutics has higher revenue and earnings than LianBio. Leap Therapeutics is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianBioN/AN/A-$110.29M-$0.81-0.33Leap Therapeutics$1.50M74.34-$81.41M-$1.93-1.51 Does the MarketBeat Community favor LIAN or LPTX? Leap Therapeutics received 289 more outperform votes than LianBio when rated by MarketBeat users. Likewise, 68.94% of users gave Leap Therapeutics an outperform vote while only 36.36% of users gave LianBio an outperform vote. CompanyUnderperformOutperformLianBioOutperform Votes436.36% Underperform Votes763.64% Leap TherapeuticsOutperform Votes29368.94% Underperform Votes13231.06% SummaryLianBio beats Leap Therapeutics on 8 of the 14 factors compared between the two stocks. Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.64M$164.65M$5.14B$9.08BDividend YieldN/A3.64%5.09%4.23%P/E Ratio-0.33115.5189.8217.18Price / SalesN/A18,239.951,116.21116.95Price / CashN/A12.7542.8937.86Price / Book0.108.504.784.78Net Income-$110.29M-$20.67M$120.23M$225.60M7 Day Performance-2.00%-1.04%-1.92%-1.23%1 Month Performance-7.97%136.65%11.49%3.36%1 Year Performance-94.24%137.57%30.57%16.60% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.27+4.9%$3.50+1,220.8%-94.2%$28.64MN/A-0.33110LPTXLeap Therapeutics1.2897 of 5 stars$3.04+3.1%$7.50+146.7%-1.0%$116.49M$1.50M-1.5340Positive NewsGap DownTARAProtara Therapeutics2.3557 of 5 stars$5.64-5.7%$22.67+301.9%+196.2%$116.35MN/A-2.1230MGXMetagenomi2.1309 of 5 stars$3.08-4.9%$16.67+441.1%N/A$115.27M$55.08M0.00236High Trading VolumeJMACMaxpro Capital AcquisitionN/A$8.34+7.8%N/A+837.6%$112.00MN/A0.002,021Gap DownINMBINmune Bio1.4805 of 5 stars$5.05+6.3%$20.00+296.0%-55.7%$111.97M$42,000.00-2.1810XFORX4 Pharmaceuticals4.3341 of 5 stars$0.65-2.6%$3.50+436.2%-16.4%$111.34MN/A-8.2280Gap DownADVMAdverum Biotechnologies4.2094 of 5 stars$5.33-0.7%$27.83+422.2%-40.0%$110.88M$1M-0.90190Analyst DowngradeNews CoverageCRDLCardiol Therapeutics2.2579 of 5 stars$1.33-0.4%$8.75+560.4%+44.0%$108.26M$60,000.00-3.4120Analyst ForecastAnalyst RevisionNews CoverageGap DownDERMJourney Medical2.548 of 5 stars$5.04-1.0%$9.38+86.0%N/A$105.29M$79.18M-5.4190ANROAlto Neuroscience3.2563 of 5 stars$3.84+0.3%$20.00+420.8%N/A$103.57M$210,000.000.00N/A Related Companies and Tools Related Companies LPTX Alternatives TARA Alternatives MGX Alternatives JMAC Alternatives INMB Alternatives XFOR Alternatives ADVM Alternatives CRDL Alternatives DERM Alternatives ANRO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIAN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIAN Stock Alerts